Vaxart, Inc.
VXRT
$0.58
$0.022.70%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 439.32% | 726.68% | 784.27% | 479.58% | 433.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 439.32% | 726.68% | 784.27% | 479.58% | 433.43% |
| Cost of Revenue | 132.99% | 171.62% | 170.25% | 78.55% | 27.26% |
| Gross Profit | 243.62% | 178.40% | 37.63% | 28.31% | 34.27% |
| SG&A Expenses | -7.67% | -15.26% | -19.07% | -20.84% | -19.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 107.96% | 130.74% | 122.75% | 53.11% | 15.24% |
| Operating Income | 166.80% | 127.26% | 31.88% | 26.04% | 30.16% |
| Income Before Tax | 164.88% | 125.20% | 30.08% | 25.27% | 29.03% |
| Income Tax Expenses | 32.26% | 83.08% | 19.38% | 10.75% | 11.91% |
| Earnings from Continuing Operations | 163.83% | 124.39% | 29.91% | 25.13% | 28.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 163.83% | 124.39% | 29.91% | 25.13% | 28.90% |
| EBIT | 166.80% | 127.26% | 31.88% | 26.04% | 30.16% |
| EBITDA | 194.61% | 146.40% | 36.13% | 29.67% | 34.02% |
| EPS Basic | 156.49% | 118.32% | 46.83% | 47.19% | 49.90% |
| Normalized Basic EPS | 157.42% | 118.96% | 46.93% | 47.27% | 50.01% |
| EPS Diluted | 155.17% | 117.51% | 46.45% | 46.85% | 49.60% |
| Normalized Diluted EPS | 157.24% | 118.87% | 46.93% | 47.27% | 50.01% |
| Average Basic Shares Outstanding | 7.62% | 13.92% | 26.28% | 40.77% | 44.06% |
| Average Diluted Shares Outstanding | 7.84% | 13.96% | 26.28% | 40.77% | 44.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |